📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Discovery of the first potent and selective avß5 integrin inhibitor based on an amide-containing core. (2020)

First Author: Lippa RA

Attributed to: Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier Nation funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejmech.2020.112719

PubMed Identifier: 32865176

Publication URI: http://europepmc.org/abstract/MED/32865176

Type: Journal Article/Review

Volume: 208

Parent Publication: European journal of medicinal chemistry

ISSN: 0223-5234